Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Engineered ion channels are modified or synthetic versions of naturally occurring ion channels. They are designed to probe, manipulate, or control cellular excitability and signaling with high specificity for research, therapeutic, or biotechnological applications. These channels can be engineered to respond to exogenous triggers such as light (optogenetics), chemicals (chemogenetics), temperature, stretch/mechanical force, ultrasound/magnetic fields. Common engineering approaches include mutagenesis, domain fusion, and incorporation into gene therapy vectors for targeted expression in vivo. Applications include dissecting physiological roles of specific channel types, probing structure-function relationships, modulating tissue activity, and serving as biosensors. They hold therapeutic potential for gene/cell therapies aimed at restoring normal excitability patterns in diseased tissues.
Modulation of ion flux across cell membranes, leading to changes in membrane potential and cellular excitability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Engineered Ion Channel.